KUR-112 (Kuros Biosciences)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameKUR-112 (Kuros Biosciences)
Drug Alias NameTGplPTH1-34I-040302KUR-112
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionParathyroid hormone receptor agonistsOsteogenesis stimulants
TargetsParathyroid hormone receptor
Therapy Area/IndicationsBone Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKuros Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuros Biosciences
Active IndicationsN/A
Inactive IndicationsBone Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A